ALTER — Theradiag SA Share News
0.000.00%
Last trade - 00:00- €16.44m
- €12.36m
- €12.20m
Brief: Biosynex Says It Holds 18.82% Of Theradiag Capital
Brief: Theradiag H1 Operating Loss Narrowed To EUR 0.2 Million
Brief: Theradiag Reports FY Operating Loss Of 0.6 Million Euros
Brief: Theradiag FY Revenue Up At 10.4 Million Euros
Brief: Theradiag To Supply ORGENTEC With Quality Control Reagents
Brief: Theradiag: CE Marking For 4 New I-Tracker Test Kits
Brief: Theradiag Announces Clinical Study That Meets French National Authority For Health Requirements Highlights Quality Of Tests
Brief: Theradiag Obtains EUR 1.9 Million State-Guaranteed Loan
Brief: Theradiag Opens New Site In Tours
French and Benelux stocks-Factors to watch
Brief: Theradiag H1 Net Result Turns To Loss Of EUR 229,000
Brief: Theradiag Launches Antigen COVID-19 Detection Test In France
Brief: Theradiag Reports End-June Cash Position At 1.7 Million Euros
Brief: Theradiag And University Of Tours Sign Two Agreements
Brief: Theradiag: To Date, 4 COVID-19 Tests Approved By French National Reference Center
Brief: Theradiag Confirms Approval Of RT-PCR Test By National Reference Center Of Paris
Brief: Theradiag Expects 2020 Revenue To Be Negatively Impacted By Covid-19
Brief: Theradiag FY Net Profit Grows To 348,000 Euros
Brief: Theradiag FY Revenue Up At 9.6 Million Euros